In a dedicated MASLD substudy involving people with obesity and significant liver fat, retatrutide produced effects that many hepatologists considered unprecedented for a drug still in phase 2
I have been out of it for a week, and my energy levels have taken a toll
ongoing membership varies by plan and medication 6-month estimate: Varies by plan and coverage Insurance: Yes Self-pay: Yes Clinical Features Lab testing: No Dietitian access: Yes Verified Pharmacy: N/A Brand-name only (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda) BBB Rating: B Delivery & Access Format: Both Nationwide telehealth: Yes Speed: Moderate Spanish-speaking providers: Not available Start your GLP-1 weight loss journey with WeightWatchers Clinic today Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice
Current guidelines from the American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity (IFSO) support consideration in patients with BMI 35 kg/m regardless of comorbidities, or BMI 30-34.9 kg/m with metabolic disease
Side effects are mostly GI symptoms, and these are much less problematic at lower doses with slow titration
The practical reality is that many purchasers use these compounds for personal use rather than formal research
